Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.510
-0.330 (-17.93%)
At close: Feb 27, 2026, 4:00 PM EST
1.528
+0.018 (1.22%)
After-hours: Feb 27, 2026, 7:54 PM EST
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $47.65 million as of February 27, 2026. Its market cap has decreased by -70.34% in one year.
Market Cap
47.65M
Enterprise Value
-78.62M
1-Year Change
-70.34%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $47.65M, a decrease of -79.73%. That is a compound annual growth rate of -38.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 47.65M | -37.34% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 61.51M |
| Mereo BioPharma Group | 61.42M |
| Instil Bio | 60.97M |
| NeurAxis | 60.61M |
| Metagenomi Therapeutics | 60.07M |
| ImmuCell | 59.25M |
| Tevogen Bio Holdings | 58.32M |
| Radiopharm Theranostics | 57.88M |